Clinical trials test the safety and efficacy of investigational products. At Texas Diabetes & Endocrinology we focus on researching devices and medications for the treatment of diabetes, thyroid disorders, cholesterol, obesity and osteoporosis. We have studies starting enrollment throughout the year. Please contact us if you are interested in participating. Research patients may receive study medications, health procedures and lab work at no cost.

Call us today! (512) 334-3505

Injectable Cholesterol Medication (Austin office)
12 weeks, 4 office visits, 2 phone contacts
Compensation: $200 ($50 per office visit)
Patient Criteria:
Diagnosed with High Cholesterol
Ages 18-80
Stable dose > 4 weeks of approved cholesterol medication

Oral Cholesterol Medication (Austin & Round Rock office)
18-19 weeks, 9 office visits
Compensation: $50 per office visit
Patient Criteria:
Age 18-80
BMI 18-45
Participants must be willing to washout cholesterol medication

Testosterone Topical Solution (Austin & Round Rock office)
10-12 weeks, 8 office visits
Compensation: $400 ($50 per office visit)
Patient Criteria:
Male patients > 18 years
History of  unsuccessful treatment with a testosterone gel
Participants must be willing to washout testosterone medication

Long-Acting Medication (Austin office)
47 weeks, 10 office visits
Compensation: $1000
Patient Criteria:
Type 2 diagnosis > 3 months
Age 18-80
BMI 25-45
A1C 7.5 – 10%

Injection Device Study (Austin & Round Rock office)
4 weeks; 3 office visits, 2 phone contacts
Compensation: $150 ($50 per office visit)
Patient Criteria:
Type 2 Diabetes
> 18 years old
BMI 23-45
A1C < 8.5%
No history of injections

Fast-Acting Insulin (Austin & Round Rock office)
37 – 63 weeks, 14 – 18 office visits, 23 – 46 phone contacts
Compensation: $50 per office visit
Patient Criteria:
Type 1 diagnosis > 1 year
BMI < 35
A1C 7.0 – 9.5%
On multiple daily injections

Injectable Medication in Type 1’s (Austin & Round Rock office)
48 weeks, 16 office visits, 23 phone contacts
Compensation: $800 ($50 per office visit)
Patient Criteria:
Type 1 diagnosis > 1 year
Age 18-75
A1C 7.0 – 9.5%
On multiple daily injections